Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2021-11-22 00:00:00 ET · period of report 2021-11-18 · accession 0001209191-21-066261 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2021-11-22	2021-11-18	RXRX	Larson Tina Marriott	Pres, COO	S - Sale	$18.92	-2,500	50.0K	-5%	-$47.3K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2021-11-18	S	D	1,798	$18.81	50,702	D	—	—	(F2) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $18.10 to $19.06 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
2	Common	Class A Common Stock	2021-11-18	S	D	702	$19.20	50,000	D	—	—	(F3) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $19.13 to $19.26 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.